Media Coverage

Media Coverage

Read how VistaGen’s intention to revolutionize mental health medicine is causing a buzz in the media.

BioWorld logo image
CBC-funded Affamed merges with Everinsight, extends portfolio with Kissei PD candidate
Read
HCP Live logo image
Michael Liebowitz, MD, VistaGen CNS Clinical and Regulatory Advisory Board Member and Pivotal Phase 3 Principal Investigator: The Mental Health Impact of COVID-19
Read
Life Science Leader logo image
The Future of Anxiety Treatment Will Be Drastically Different
Read
Applied Clinical Trials logo image
Pushing Late-Stage Treatments Forward in the Clinic
Read
Pharmaceutical Technology logo image
Treating social anxiety disorder: VistaGen and EverInsight collaborate in Asian markets
Read
Thepharmaletter logo image
VistaGen out-licenses rights to anxiety disorder candidate in Asia territories
Read
MD Magazine logo image
DocTalk Podcast: The Psychological Damage of the COVID-19 Pandemic
Read
Taylor & Francis logo image
An interview with Shawn Singh: Chief Executive Officer and Director of VistaGen Therapeutics
Read
GENE Online logo image
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
Read